PHARMACEUTICAL FORMULATIONS OF INDOLEAMINE 2, 3-DIOXYGENASE INHIBITORS Application WO-2021050653-A1 World Intellectual Property Organisation (WIPO) 18 Mar 2021
Formulations of 3-(5-amino-2-methyl-4-oxo-4H-quinazolin-3-yl)-piperidine-2,6-dione Grant US-10064863-B2 United States of America 04 Sep 2018
Pharmaceutical composition for the treatment of inflammatory disorders Application JP-2017505330-A Japan 16 Feb 2017